Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 4, 2005 - Issue 4
Submit an article Journal homepage
170
Views
24
CrossRef citations to date
0
Altmetric
Review

Systemic quinolone antibiotics in children: a review of the use and safety

Richard W Grady The University of Washington Medical Center, USA. [email protected]
Pages 623-630 | Published online: 12 Jul 2005

Bibliography

  • FILE T, SLAMA T: Fluoroquinolones: Today and Into the Future. Medscape Reviews (2000).
  • GORMAN R: The March Toward Rational Therapeutics in Children. Pediatr. Infect. Dis. J. (2003) 22(12):1119–1123.
  • GRADY R: Safety Profile of Quinolone Antibiotics in the Paediatric Population. Pediatr. Infect. Dis. J. (2003) 22(12):1128–1132.
  • REDMOND AO: Risk-benefit experience of ciprofloxacin use in paediatric patients in the United Kingdom. Pediatr. Infect. Dis. (1997) 16(1):147–149; discussion 160–162.
  • BALL P, TILLOTSON G: Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Sal (1995) 13(6):343–358.
  • LIPSKY BA: Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin. Infect. Dis. (1999) 28:352–364.
  • FRIEDRICH LV, DOUGHERTY R: Fatal hypoglycemia associated with levofloxacin. Pharmacotherapy (2004) 24(12):1807–1812.
  • LIN G, HAYS DP, SPILLANE L: Refractory hypoglycemia from ciprofloxacin and glyburide interaction. I. Toxicol Toxicol (2004) 42(3):295–297.
  • LEBLANC M, BELANGER C, COSSETTE P: Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy. Pharmacotherapy (2004) 24(7):926–931.
  • COBLIO NA, MOWREY K, MCCRIGHT P, MEANS H, MCCORMICK MT: Use of a data warehouse to examine the effect of fluoroquinolones on glucose metabolism. Am. I. Health Syst. Pharm. (2004) 61(23):2545–2548.
  • HARIA M: Trovafloxacin. Drugs (1997) 54:435–445.
  • ECHOLS R: Introduction: historical perspective - use of ciprofloxacin in children. Pediatr. Infect. Dis. J. (1997) 16(1)89–90.
  • GRADY RW: Urinary Tract Infections in Children, In: Essential Urology, J. Potts (Ed). 2004, Humana Press: Totowa, NJ.33–47.
  • BATISKY D: Paediatric urinary tract infections. Pediatr. Ann. (1996) 25(5):266, 269-276.
  • ORELLANA P, BAQUENADO P, RANGARAJAN P et al: Relationship between acute pyelonephritis, renal scarring, and vesicoureteral reflux. Results of a coordinated research project. Pediatr. Nephrol (2004) 19(10):1122–1126.
  • HOBERMAN A, WALD ER, HICKEY RW et al: Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics (1999) 104(1 Pt 1):79–86.
  • LATIFF Z, ZULKIFLI SZ, JAMAL R: Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia. Malays.j Pathol (2002) 24(2):83–89.
  • MULLEN C, PETROPOULOS D, ROBERTS W et al.: Outpatient treatment of fever and neutropenia for low-risk paediatric cancer patients. Cancer (1999) 86:126–134.
  • MULLEN C: Ciprofloxacin in treatmentof fever and neutropenia in paediatric cancer patients. The Paediatric Infectious Diseases Journal (2003) 22:1128–1132.
  • POSTNIKOV SS, SEMYKIN SI, KAPRANOV NI, PEREDERKO LV, POLIKARPOVA SV, KHAMIDULLINA KF: Evaluation of tolerance and efficacy of pefloxacin in the treatment and prevention of severe infections in children with mucoviscidosis and aplastic anemia. Antibiot. Khimioter. (2000) 45(8):25–30.
  • POSTNIKOV SS: Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis. Antibiot. Khimioter. (2001) 46(3):16–20.
  • RICHARD DA, NOUSIA-ARVANITAKIS S, SOLLICH V, HAMPEL BJ, SOMMERAUER B, SCHAAD UB: Oral ciprofloxacin versus intravenous ceftazidime plus tobramycin in paediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group. Pediatr. Infect. Dis.1 (1997) 16(6)572-578.
  • CHEASTY T, DAY M, THRELFALL EJ: Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy. Clia Microbiol Infect. (2004) 10(10:1033–1035.
  • DAGAN D, ORR N, YAVZORI M et al: Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel. Eur. I Clin. Microbiol Infect. Dis. (2002) 21(12):887–889.
  • GENDREL D, CHALUMEAU M, MOULIN F, RAYMOND J: Fluoroquinolones in paediatrics: a risk for the patient or for the community? Lancet Infect. Dis. (2003) 3(9):537–546.
  • NIYOGI SK, MITRA U, DUTTA P: Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India. fpn J. Infect. Dis. (2001) 54(3):121–122.
  • GUERIN PJ, BRASHER C, BARON E et al: Shigella dysenteriae serotype 1 in west Africa: intervention strategy for an outbreak in Sierra Leone. Lancet (2003) 362(9385):705–706.
  • LAUREILLARD D, PAQUET C, MALVY D: Ciprofloxacin in the treatment of dysentery caused by Type 1 Shigella dysenteriae during an epidemic in Rwandan refugees in Goma in 1994.Sante (1998) 8(4):303–305.
  • KHALIL K, KHAN SR, MAZHAR K, KAIJSER B, LINDBLOM GB: Occurrence and susceptibility to antibiotics of Shigella species in stools of hospitalized children with bloody diarrhea in Pakistan. Am. I. Trop. Med. Hyg. (1998) 58(6):800–803.
  • ISLAM MR, ALAM AN, HOSSAIN MS, MAHALANABIS D, HYE HK: Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children. I. Trop. Pediatr. (1994) 40(6):320–325.
  • SALAM MA, DHAR U, KHAN WA, BENNISH ML: Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Lancet (1998) 352(9127):522–527.
  • BHATTACHARYA K, BHATTACHARYA MK, DUTTA D et al: Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. Acta Paediatr. (1997) 86(3):319–320.
  • LEIBOVITZ E, JANCO J, PIGLANSKY Let al: Oral ciprofloxacin versus intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in 629 children. Pediatr. Infect. Dis. (2000) 19(11):1060–1067.
  • FONTAINE 0: Antibiotics in the management of shigellosis in children: what role for the quinolones? Rev. Infect. Dis. (1989) 11\(Suppl. 5):S1145–S1150.
  • HAMPEL B, HULLMAN R, SCHMIDT H: Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use - safety report. Pedatr. Infect. Dis. (1997) 1997 16(1):127–129.
  • HAMPEL B, HULLMANN R, SCHMIDT H: Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report. Pediatr. Infect. Dis. J. (1997) 16(1):127–129; discussion 160–162.
  • CHALUMEAU M, TONNELIER S, D'ATHIS P et al: Fluoroquinolone safety in paediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics (2003) 111(6 Pt 1):e714–e719.
  • STAHLMANN R: Clinical toxicological aspects of fluoroquinolones. Toxicol Lett. (2002) 127(1-3):269–277.
  • STAHLMANN R, LODE H: Toxicity of quinolones. Drugs (1999) 58\(Suppl. 2):37–42.
  • STAHLMANN R: Children as a special population at risk-quinolones as an example for xenobiotics exhibiting skeletal toxicity. Arch. Toxicol (2003) 77(1):7–11.
  • SHAKIBAEI M, DE SOUZA P, VAN SICKLE D, STAHLMANN R: Biochemical changes in Achilles tendon from juvenile dogs after treatment with ciprofloxacin or feeding a magnesium-deficient diet. Arch. Toxicol (2001) 75(6):369–374.
  • AMACHER D, SCHOMAKER SJ, GOOTZ TD, MCGUIRK PR: Proteoglycan and procollagen synthesis in rat embryo limb bud cultures treated with quinolone antibacterials. Allem. Methods Toxicol (1989) 7:307–312.
  • JORGENSEN C, ANAYA JM, DIDRI C et al.: Arthropathy with Achilles tendon involvement induced by pefloxacin. Rev Rheum. Mal. Osteoartic. (1991) 58:623–625.
  • WILLIAMS J: Achilles tendon lesions in sport. Sports Med. (1986) 3:114–135.
  • MOVIN T, GAD A, GUNTNER P, FOLDHAZY Z, ROLF C: Pathology of the Achilles tendon in association with ciprofloxacin treatment. Foot Abide(1997) 18(5):29729–9.
  • SCHLUTER G: Ciprofloxacin: review of potential toxicologic effects. Am. J. Med. (1987) 82 (Suppl. 4A):91–93.
  • GOUGH A, BARSOUM NJ, MITCHELL L, MCGUIRE EJ, DE LA IGLESIA FA et al: Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl. Pharmacol (1979) 51(1):177–187.
  • JICK S: Ciprofloxacin safety in a paediatric population. Pediatr. Infect. Dis. J. (1997) 16(1):130–133; discussion 133–4, 160–162.
  • MASLANKA T, JAROSZEWSKI JJ, Chrostowska M: Pathogenesis of quinolone-induced arthropathy: a review of hypotheses. Poi. Vet. Sci. (2004) 7(4):323–331.
  • NAGAI A, MIYAZAKI M, MORITA T et al: Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs. ToxicoL Set. (2002) 27(3):219–228.
  • SIMONIN MA, GEGOUT-POTTIE P, MINN A, GILLET P, NETTER P: Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob. Agents Chemother. (2000) 44(4):867–872.
  • ROYER RJ: Adverse drug reactions with fluoroquinolones. Therapie (1996) 51(4):414–416.
  • POSTNIKOV SS, SEMYKIN SI, NAZHIMOV VP, NOVICHKOVA GA: On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data). Antibiot. Khimioter. (2002) 47(9):14–17.
  • NO AUTHORS LISTED: Fluoroquinolones in children: poorly defined risk of joint damage. Prescrire Int. (2004) 13(73):184–6.
  • SCHAAD U, WED GEWOOD-KRUKOJ: Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection (1987) 15:165–168.
  • SCHAAD UB: Use of the new quinolones in pediatrics. Isr. J. Med. Sd. (1994) 30(5-6):463–468.
  • CHYSKY V, KAPILA K, HULLMAN R et al: Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection (1991) 19:289–296.
  • BLACK A, REDMOND AO, STEEN HJ, OBORSKA IT et al: Tolerance and safety of ciprofloxacin in paediatric patients. I Antimicrob. Chemother. (1990) 26(Suppl. F):25–29.
  • PHILLIPS B, DAVID TJ: Pathogenesis and management of arthropathy in cystic fibrosis. J. R. Soc. Med. (1986) 79\(Suppl. 12):44–50.
  • PRADHAN K, ARORA NK, JENA A, SUSHEELA AK, BHAN MK: Safety of ciprofloxacin therapy in children: magnetic resonance imaging, body fluid levels of fluoride and linear growth. Acta Pediatr. (1995) 84(5):555–560.
  • ADAM D: Use of quinolones in paediatric patients. Rev. Infect. Dis. (1989) 11:1163–1165.
  • SALAM M, DHAR U, KHAN WA, BENNISH ML: Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Lancet (1998). 352(9127):522–527.
  • LEIBOVITZ E, JANCO J, PIGLANSKY L et al: Oral ciprofloxacin versus intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr. Infect. Dis. (2000) 19(10:1060–1067.
  • SCHACHT P, ARCIERI G, BRAN OLTE J et al: Worldwide clinical data on efficacy and safety on ciprofloxacin. Infection (1988) 16\(Suppl. 1):29–43.
  • KUBIN R: Safety and efficacy of ciprofloxacin in paediatric patients-review. Infection (1993) 21(6):413–421.

Websites

  • www.ciprousa.comiticp/utilities/pLasp. Ciprofloxacin prescribing information. 2004, Bayer Pharmaceutical Corp.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.